## **Core Concept**
The question tests understanding of the pharmacokinetics of nitrates, specifically their susceptibility to first-pass metabolism. First-pass metabolism refers to the rapid metabolism of a drug after oral administration, resulting in reduced bioavailability. Nitrates are commonly used to treat angina pectoris.

## **Why the Correct Answer is Right**
The correct answer, **isosorbide dinitrate (C)**, is known to undergo extensive first-pass metabolism. When taken orally, it is rapidly metabolized in the liver to its active metabolites, isosorbide-5-mononitrate and isosorbide-2-mononitrate. This extensive first-pass effect significantly reduces its oral bioavailability. Isosorbide dinitrate is often administered sublingually or through a transdermal patch to bypass this effect.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Nitroglycerin primarily undergoes first-pass metabolism as well but is usually administered sublingually, intravenously, or transdermally to avoid this issue. However, the question seems to focus on a nitrate that "can" undergo first-pass metabolism, making the specificity of the question towards oral administration crucial.
- **Option B:** Isosorbide-5-mononitrate is a metabolite of isosorbide dinitrate and does not undergo significant first-pass metabolism because it is already a product of the metabolic process.
- **Option D:** Nitroglycerin is given sublingually or via transdermal patches to avoid first-pass metabolism, but like isosorbide dinitrate, it does undergo first-pass metabolism if taken orally.

## **Clinical Pearl / High-Yield Fact**
A key clinical point to remember is that for drugs with significant first-pass metabolism, alternative routes of administration (like sublingual, intravenous, or transdermal) can be used to enhance bioavailability. For nitrates, this is particularly relevant because their effectiveness in treating angina can be compromised by extensive first-pass metabolism.

## **Correct Answer:** . Isosorbide dinitrate